64445

Injection, anesthetic agent; sciatic nerve, single

CPT code 64445 represents a specialized somatic nerve block procedure involving the targeted injection of a local anesthetic agent, which is frequently supplemented with a corticosteroid medication, directly adjacent to or into the surrounding fascial sheath of the sciatic nerve. The sciatic nerve is the largest and longest individual nerve in the human body, originating from the lumbosacral plexus, specifically nerve roots L4 through S3. It extends deep through the gluteal region, down the posterior aspect of the thigh, and eventually branches to innervate the entire lower leg, ankle, and foot. Consequently, this procedure serves multiple fundamental clinical purposes, including diagnostic evaluation, therapeutic intervention, and regional surgical anesthesia. Diagnostically, the sciatic nerve block is utilized to definitively confirm the sciatic nerve as the specific anatomical pain generator. This is crucial for differentiating peripheral nerve entrapment syndromes from central lumbar radiculopathy, facet joint pain, or other overlapping lower extremity pathologies. Therapeutically, the synergistic combination of a corticosteroid and a local anesthetic agent can significantly reduce perineural inflammation, alleviate deep muscle spasms commonly associated with conditions such as piriformis syndrome, and provide extended, meaningful pain relief for patients suffering from severe sciatica, traumatic nerve injuries, or complex regional pain syndrome (CRPS) affecting the lower limb. Furthermore, as a highly effective anesthetic intervention, a sciatic nerve block is routinely employed by anesthesiologists and pain management specialists as a regional anesthesia technique. It is heavily utilized for complex surgical procedures involving the knee, posterior thigh, lower leg, ankle, and foot, very often administered in combination with a femoral nerve block or saphenous nerve block to achieve complete anesthesia of the extremity. During the execution of the procedure, the patient is meticulously positioned in a lateral decubitus, prone, or Sims position, depending on the physician's preferred anatomical approach (e.g., transgluteal, subgluteal, or popliteal). The physician carefully sterilizes the overlying skin in the chosen region using standard surgical aseptic techniques. Utilizing precise anatomical landmarks and highly recommended real-time image guidance, such as high-frequency ultrasound or fluoroscopy, the physician introduces a specialized echogenic block needle. The needle is slowly and deliberately advanced until the tip reaches the epineurium of the sciatic nerve. Peripheral nerve stimulation may also be employed concurrently to confirm exact proximity by eliciting specific motor responses, such as plantar flexion or dorsiflexion of the foot. Once the correct needle tip position is visually and physiologically confirmed, a mandatory negative aspiration test is performed to absolutely rule out inadvertent intravascular placement. This is followed by the slow, incremental injection of the prepared pharmacological mixture. The patient is subsequently monitored closely in a clinical setting for block efficacy, the onset of targeted sensory or motor blockade, and any potential adverse reactions, particularly local anesthetic systemic toxicity (LAST).

Clinical Indications

  • Sciatica or sciatic neuralgia unresponsive to conservative management
  • Piriformis syndrome causing sciatic nerve entrapment and inflammation
  • Regional anesthesia for surgical procedures involving the lower leg, ankle, or foot
  • Post-operative pain management following major lower extremity orthopedic surgery
  • Complex Regional Pain Syndrome (CRPS) affecting the lower extremity
  • Diagnostic evaluation to isolate and confirm the anatomical pain generator in the lower back and leg
  • Traumatic injury to the lower extremity requiring acute pain control

Procedure Steps

  1. Place the patient in the prone, lateral decubitus, or Sims position depending on the chosen anatomical approach (e.g., classic posterior, subgluteal, or popliteal).
  2. Sterilize the skin over the injection site using standard aseptic technique with agents such as chlorhexidine or povidone-iodine.
  3. Identify anatomical landmarks and utilize real-time image guidance (ultrasound or fluoroscopy) to clearly visualize the sciatic nerve and surrounding vascular structures.
  4. Administer a superficial local anesthetic subcutaneously to numb the planned needle insertion site.
  5. Insert and advance the specialized block needle toward the sciatic nerve, utilizing real-time imaging or a peripheral nerve stimulator to confirm precise needle tip placement (observing for a motor response such as foot twitch if using a stimulator).
  6. Perform a negative aspiration test to ensure the needle tip is not positioned intravascularly, minimizing the risk of systemic toxicity.
  7. Slowly inject the therapeutic or anesthetic mixture (local anesthetic, often combined with a corticosteroid) while monitoring the patient's response and observing the perineural spread of the fluid via ultrasound.
  8. Withdraw the needle carefully, apply a sterile bandage or dressing to the injection site.
  9. Transfer the patient to a recovery area for post-procedure monitoring, assessment of block efficacy, and observation for any adverse effects.

Coding Guidelines

  • Do not report CPT code 64445 in conjunction with a continuous infusion via catheter. For continuous sciatic nerve block, use CPT code 64446.
  • Imaging guidance (e.g., ultrasound 76942, fluoroscopy 77002) is not inherently included in 64445 and may be reported separately if properly documented and medically necessary.
  • If the procedure is performed bilaterally, append modifier 50 to 64445. Do not bill as two separate line items unless specific payer guidelines dictate otherwise.
  • Do not code 64445 when the sciatic block is performed by the primary operating surgeon as part of the global surgical package for routine post-operative pain control, unless an exception applies (e.g., appended with modifier 59 or XU with a distinct, documented request by the surgeon for independent pain management).
  • Appropriate ICD-10 diagnosis coding must be definitively linked to establish medical necessity (e.g., M54.3- series for sciatica or G57.0- series for lesion of the sciatic nerve).